| 000 | 01816cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030228.0 | ||
| 008 | 100516s2009 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.11.10.M.Sc.2009.Ol.S | ||
| 100 | 0 | _aOla Omar Abdelhalim Abouzeid | |
| 245 | 1 | 0 |
_aSerum transforming growth factor beta-1 in vitiligo : _bA possible marker of disease activity / _cOla Omar Abdelhalim Abouzeid ; Supervised Nahla Shoukry Hunter , Dina Kadey Ismail , Azza Ahmed Ali |
| 246 | 1 | 5 | _aعامل النمو المحول بيتا - 1 فى المصل فى مرض البهاق كدلالة لنشاط المرض |
| 260 |
_aCairo : _bOla Omar Abdelhalim Abouzeid , _c2009 |
||
| 300 |
_a103 P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Dermatology and Venerology | ||
| 520 | _aVitiligo is an idiopathic depigmentary skin disorder characterized by selective destruction of melanocytes. Recent observations support the role of altered cellular immunity, autoimmunity, and a role for cytokines in the pathogenesis of vitiligo. The characteristic lesion in vitiligo is a sharply demarcated milky white macule or patch which is surrounded by normal skin. Vitiligo may be divided into localized generalized and universal | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aDisease activity | |
| 653 | 4 | _aTransformin growth factor beta-1 | |
| 653 | 4 | _aVitiligo | |
| 700 | 0 |
_aAzza Ahmed Ali , _eSupervisor |
|
| 700 | 0 |
_aDina Kadey Ismail , _eSupervisor |
|
| 700 | 0 |
_aNahla Shoukry Hunter , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSamia _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c30313 _d30313 |
||